hotspot -WSS

hotspot

author：focus 2025-09-28 23:29:12 - browse：3611

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： WHO recommends dropping component of many flu vaccines

focus

hotspot

WSS

Surgery pushed Ben Carson to fame

Data show record exodus of life scientists from academia

Would Medicare drug price negotiations stall in a shutdown?

Why Novartis is going to walk from its acquisition of MorphoSys

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Readout LOUD: Venture capital, Gilead, and more M&A

explore

hotspot

knowledge

23andMe had bad news about my health. I wish a person had delivered it

Global cancer cases to surge 77% by 2050, WHO report says

ChatGPT in medicine: STAT answers readers' burning questions

Listen: Who gets the credit for GLP

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Menendez indictment could see pharma lose a key ally

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Sports medicine is finally prioritizing gender equality

Why Novartis is going to walk from its acquisition of MorphoSys

leisure time

WHO recommends dropping component of many flu vaccines

Biogen shutters digital health group, ends Apple study, in cost cutting move

Readout LOUD: Venture capital, Gilead, and more M&A

Updated Covid vaccine has 54% effectiveness, new study suggests

FDA seeks to regulate lab

Address the ethical violations that led to 'Three Identical Strangers'

focus

hotspot

entertainment

hotspot